Assertio Holdings (ASRT) said, on May 1, 2026, Assertio and Garda Therapeutics entered into an Amended and Restated Agreement and Plan of Merger, pursuant to which Garda has increased its offer to acquire all outstanding shares of Assertio to $21.80 per share in cash with no contingent value right.
Following the successful completion of the tender offer, Garda will acquire any remaining shares through a second-step merger at the same price. Upon completion, Assertio's common stock will no longer be listed on Nasdaq.
In pre-market trading on NasdaqCM, Assertio shares are up 17.27 percent to $21.66.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.